BUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'

Reuters2024-12-02

BUZZ-Voyager <a href="https://laohu8.com/S/LENZ">Therapeutics</a> rises after Citigroup starts coverage with 'buy'

** Biotech company Voyager Therapeutics' VYGR.O shares rise about 1% to $6.92 premarket

** Citigroup starts coverage on stock with "buy" rating and PT at $12

** Last week, Wedbush analyst Yun Zhong also started coverage on stock with "outperform" rating and PT at $11

** All ten brokerages rate the stock "buy" or higher; median PT on the stock is $18 - LSEG

** As of last close, stock down 18.7% YTD

(Reporting by Jaiveer Singh Shekhawat in Bengaluru)

((JaiveerSingh.Shekhawat@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2488750696?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-02 20:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2488750696","market":"us","top_or_hot":-1,"title":"BUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Voyager <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> rises after Citigroup starts coverage with 'buy'</title></head><body><p>** Biotech company Voyager Therapeutics' <span>VYGR.O</span> shares rise about 1% to $6.92 premarket</p><p>** Citigroup starts coverage on stock with \"buy\" rating and PT at $12</p><p>** Last week, Wedbush analyst Yun Zhong also started <span>coverage</span> on stock with \"outperform\" rating and PT at $11</p><p>** All ten brokerages rate the stock \"buy\" or higher; median PT on the stock is $18 - LSEG</p><p>** As of last close, stock down 18.7% YTD</p><p> (Reporting by Jaiveer Singh Shekhawat in Bengaluru)</p><p> ((JaiveerSingh.Shekhawat@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-02 20:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nL3N3N30R5:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'** Biotech company Voyager Therapeutics' VYGR.O shares rise about 1% to $6.92 premarket** Citigroup starts coverage on stock ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nL3N3N30R5:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VYGR","symbol_name":"Voyager Therapeutics Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nL3N3N30R5:1","article_id":"2488750696","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488750696","pubTimestamp":1733144127,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'** Biotech company Voyager Therapeutics' VYGR.O shares rise about 1% to $6.92 premarket** Citigroup starts coverage on stock w","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VYGR":"Voyager Therapeutics Inc","BK4139":"生物科技"},"translate_title":"花旗集团开始给予“买入”评级后，Voyager Therapeutics股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VYGR":0.9},"content_text":"BUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'** Biotech company Voyager Therapeutics' VYGR.O shares rise about 1% to $6.92 premarket** Citigroup starts coverage on stock with \"buy\" rating and PT at $12** Last week, Wedbush analyst Yun Zhong also started coverage on stock with \"outperform\" rating and PT at $11** All ten brokerages rate the stock \"buy\" or higher; median PT on the stock is $18 - LSEG** As of last close, stock down 18.7% YTD (Reporting by Jaiveer Singh Shekhawat in Bengaluru) ((JaiveerSingh.Shekhawat@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488750696"}